
Kayentis names four committee members
pharmafile | May 28, 2015 | Appointment | Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Patrizia Paterlini-Brechot, Pierre-Olivier Goineau, Ronan Roussel, Stephen Senn, kayentis
French software solutions provider for clinical trials Kayentis has formed a strategic committee comprising four industry veterans.
Accepting director Guillaume Juge’s invitation to join the body, are Patrizia Paterlini-Brechot (pictured), Pierre-Olivier Goineau, Ronan Roussel and Stephen Senn.
Paterlini-Bréchot is a professor of Cellular Biology and Oncology at the Necker-Enfants malades faculty of Medecine in Paris, and is the inventor of the ISET test (Isolation by Size of Epithelial Tumor cells), a non-invasive diagnostic method for solid cancers.
Goineau is the co-founder of Erytech pharma and president of Goineau Development & Finance and France Biotech. Roussel is a Professor of Diabetology and Endocrinology at the Bichat-Claude Bernard hospital and the Cordeliers Research Centre.
Senn is a Professor of Statistics and a specialist in clinical research methodology, and head of unit at the Luxembourg Institute of Health’s ‘research methodology and statistics’ competence centre.
Juge says: “The main aim of this strategic committee is to help Kayentis develop its product offering and roadmap. Members will also be given the opportunity to contribute to the international development of a French clinical research organisation.”






